Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Link

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Heliyon|March 11, 2024
Sendai virus is robust and consistent in delivering genes into human pancreatic cancer cellsDmytro Grygoryev, Taelor Ekstrom, Elise Manalo, et al.
Journal of Chemical Technology and Biotechnology (Oxford, Oxfordshire : 1986)|September 14, 2012
Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activityJianya Y Huan, Roberto Meza-Romero, Jeffery L Mooney, et al.
Molecular Cancer Research : MCR|April 5, 2022
T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62Colin J Daniel, Carl Pelz, Xiaoyan Wang, et al.
STAR Protocols|March 6, 2025
Protocol to purify and culture human pancreatic cancer cells from patient-derived xenograftsJulien Tessier, Dmytro Grygoryev, Marilynn Chow-Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2023
MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN SignalingRazmik Ghukasyan, Keke Liang, Kevin Chau, et al.
JCO Precision Oncology|May 26, 2021
Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes in Related Patients With Pancreatic AdenocarcinomaJason M Link, Shannon M Liudahl, Courtney B Betts, et al.
Cell Reports|January 12, 2022
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cellsEvan R Abt, Thuc M Le, Amanda M Dann, et al.
Nature Communications|January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trialZev A Wainberg, Jason M Link, Alykhan Premji, et al.
Cancer Research|September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic CancerChloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Nature Cancer|January 9, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancerJason M Link, Jennifer R Eng, Carl Pelz, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Heliyon|March 11, 2024
Sendai virus is robust and consistent in delivering genes into human pancreatic cancer cellsDmytro Grygoryev, Taelor Ekstrom, Elise Manalo, et al.
Journal of Chemical Technology and Biotechnology (Oxford, Oxfordshire : 1986)|September 14, 2012
Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activityJianya Y Huan, Roberto Meza-Romero, Jeffery L Mooney, et al.
Molecular Cancer Research : MCR|April 5, 2022
T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62Colin J Daniel, Carl Pelz, Xiaoyan Wang, et al.
STAR Protocols|March 6, 2025
Protocol to purify and culture human pancreatic cancer cells from patient-derived xenograftsJulien Tessier, Dmytro Grygoryev, Marilynn Chow-Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2023
MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN SignalingRazmik Ghukasyan, Keke Liang, Kevin Chau, et al.
JCO Precision Oncology|May 26, 2021
Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes in Related Patients With Pancreatic AdenocarcinomaJason M Link, Shannon M Liudahl, Courtney B Betts, et al.
Cell Reports|January 12, 2022
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cellsEvan R Abt, Thuc M Le, Amanda M Dann, et al.
Nature Communications|January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trialZev A Wainberg, Jason M Link, Alykhan Premji, et al.
Cancer Research|September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic CancerChloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Nature Cancer|January 9, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancerJason M Link, Jennifer R Eng, Carl Pelz, et al.
Pageof 3